This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

December 7 - 9, 2020|★ VIRTUAL EVENT, (All-Digital Format)

Garner Efficiencies in Regulatory and Reimbursement Processes in a COVID Era

The Original Forum for Life Sciences Providing Exclusive Access to FDA/CMS Regulators to Examine Shifting Regulatory and Reimbursement Policy

What to Expect


Garner the Latest Regulatory Updates
Garner the Latest Regulatory Updates
  • Discuss FDA and CMS perspectives on the impact of the pandemic on regulatory approval and reimbursement processes – Which efficiencies and process shifts are here to stay?
  • Explore trends in the decentralization and digital enablement of clinical trials - Identify next steps necessary to achieve diversity in clinical trials
  • Advancing opportunities for cross-center (CBER/CDER) approaches to incorporate patient engagement in regulatory decision-making
  • Consider next steps to realize the full potential of RWE in drug development
Examine the Latest Updates to Reimbursement Policy
Examine the Latest Updates to Reimbursement Policy
  • Understand the current state of value-based reimbursement models in the midst of the pandemic and the impact on the future of value-based care
  • Examine reimbursement status of new technologies and advanced therapies under new payment models
  • Review updates on Medicare coverage and access – Discuss CMS advancements in expanding telehealth benefits and the focus on improving plan incentives to align with what patients value
Changes in the Political Landscape and Market Trends that Impact Drug Development
Changes in the Political Landscape and Market Trends that Impact Drug Development
  • Assess the impact of the 2020 election on drug pricing reform
  • 21st Century Cures Act 2.0 – Consider the impact on drug development and patient access
  • Address challenges and opportunities in cell and gene therapy development
  • Evaluate the future for the drug development supply chain – What are the potential capabilities and pros/cons of domestic manufacturing?

Introduction Video


by Tracey Kimball

Interested in speaking opportunities?
Contact Tracey for information.

+1-781-606-2984

tracey.kimball@informa.com

Redefining Your Learning Experience

In light of the current global climate, it is more important than ever for the regulatory community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, the FDA/CMS Summit 2020, taking place December 7 - 9, has undergone a timely transformation, moving to an all‑digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.


DIGITAL CAPABILITIES AND FEATURES:
DIGITAL CAPABILITIES AND FEATURES:
  • Access to Virtual Environment
  • Audience Q&A
  • Live Polling and Benchmarking
  • Virtual Networking and Partnering
  • Live Slide Sharing
VIRTUAL PARTNERING AND NETWORKING OPPORTUNITIES:
VIRTUAL PARTNERING AND NETWORKING OPPORTUNITIES:

Who’s Who?

  • Attendee and company profiles provide insight into the delegation and sponsoring organizations
  • Advanced search capabilities to identify opportunities and potential partners

When and How to Connect?

  • Sophisticated and seamless scheduling tools to establish meeting times
  • Ease-of-use technology to enable virtual networking
COMPREHENSIVE CONTENT:
COMPREHENSIVE CONTENT:
  • 3 Days of Live Content from FDA and CMS regulators, health policy leaders, life sciences leaders and solution providers
  • On-demand access to content assets and topic resources
  • Unlimited Networking with Colleagues and Counterparts
  • Live Q&A Chats with conference faculty

Who Should Attend

You will benefit from attending this event if you are from a bio/pharma or medical device/diagnostic company with responsibilities or involvement in the following areas:


  • Regulatory Affairs
  • Government Affairs/Relations
  • Health Economics
  • Public Policy & Strategy
  • Payment and Healthcare
  • Quality
  • Patient Advocacy
  • Medicaid
  • Medicare
  • Market Access
  • R&D
  • Drug Safety
  • Rare Disease
  • Compliance
  • Gene Therapy

This conference will also benefit consultants and software providers that provide services to life science companies.

Connect and Network with Key Decision-Makers at the FDA/CMS Summit 2020

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, contact us here.